SkyCell Revolutionizes Medical Supply Chain Management with $116M Investment
In a monumental stride towards advancing global pharmaceutical logistics, SkyCell, the pioneering Swiss pharmatech firm, has announced securing $116 million in Series D funding. This landmark investment is poised to propel SkyCell’s expansion across the United States and Asia, solidifying its footprint in critical healthcare supply chains worldwide. At the heart of SkyCell’s innovation lies…
